The effects of 12-O-tetradecanoylphorbol-13-acetate (TPA), all trans-retinoic acid (RA), 5-azacytidine (5-AC), and phenobarbital (PB) on the activities of seven enzymes and/or isozymes of a diploid rat liver epithelial cell line have been studied. At 0.1 microgram/ml, TPA depressed the specific acti
Opposing effects of 12-o-tetradecanoylphorbol 13-acetate on human myeloid and lymphoid cell proliferation
✍ Scribed by M. T. Aye; J. V. Dunne
- Publisher
- John Wiley and Sons
- Year
- 1983
- Tongue
- English
- Weight
- 710 KB
- Volume
- 114
- Category
- Article
- ISSN
- 0021-9541
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
The effect of 12‐O‐tetradecanoylphorbol 13‐acetate (TPA) on human hematopoietic cells has been investigated. It was found that 1–10 ng/ml of TPA totally abrogated erythroid and granulocytic colony growth and, simultaneously in the presence of PHA, stimulated T‐lymphocyte colony formation. TPA concentrations insufficient to inhibit myeloid colony growth also failed to stimulate lymphocyte colony formation. Optimal culture conditions for the growth of these colonies required the presence of TPA, PHA, and leukocyte‐conditioned medium in the cultures. Cells within the colonies were 80–90% E‐rosette positive and by monoclonal antibody characterization contained 45–66% OKT3‐positive cells. Colony‐forming cells were found in both E‐rosette‐positive and‐negative fractions. Although by cell surface marker characterization the cells within the colonies had properties of T‐cells, the exact relationship of cells forming colonies under these conditions to those detected in other T‐cell colony assays remain to be determined.
📜 SIMILAR VOLUMES
The effect of the skin tumor-promoter TPA (12-0-tetradecanoylphorbol-13-acetate) on expression of cellular proto-oncogenes has been examined in cell lines derived from human urothelium. A single treatment with TPA (1 pg/ml) increased the transcription of clfos and c-myc proto-oncogenes at least 20-f
The ability of 12-0-tetradecanoylphorbol-I 3-acetate (TPA) and D,L-buthionine-S,R-sulphoximine (BSO) to modulate cisdiamminedichloroplatinum(ll) (CDDP) sensitivity was investigated in human ovarian cancer cell lines sensitive (KF) or with intrinsic resistance (KK and MH) to CDDP. The KK and MH cell
We have previously reported that K562/ADM, a typical P-glycoprotein-mediated multi-drug-resistant cell line, is cross-resistant t o the growth-inhibitory effect of I 2 -0tetradecanoylphorbol I 3-acetate (TPA) and non-TPA type tumor promoters. To elucidate the mechanism of crossresistance to tumor pr